Proposal Would Reduce Production Quotas for Many Drugs Key to the Opioid Crisis

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson Controlled Substances Module, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Quotas

Proposal Would Reduce Production Quotas for Many Drugs Key to the Opioid Crisis

Ken Baumgartner

August 20, 2018 at 16:53:36 ET

The Drug Enforcement Administration in an Aug. 20 Federal Register notice proposed 2019 aggregate production quotas for several Schedule I and II drugs at levels lower than 2018 (83 Fed. Reg. 42614). In particular, Schedule II quotas for fentanyl, hydrocodone, morphine and oxymorphone would be reduced. However, quotas for noroxymorphone (for conversion) and oxymorphone (for convers... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Proposal Would Reduce Production Quotas for Many Drugs Key to the Opioid Crisis

My Research Folders

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT

Oops! Subscribers must be logged in to access this content.

Not A Controlled Substances’ Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the Controlled Substances Module.

Subscription Benefits

Start Your Free Trial

Proposal Would Reduce Production Quotas for Many Drugs Key to the Opioid Crisis

My Research Folders

Related Articles

THOMPSON CONTROLLED SUBSTANCES

COMPLIANCE EXPERT

DEA RESOURCES

HELP

CONTACT